RecruitingNCT05942807
Observational Monocentric Study on Biliary Tract Cancer (BABEL)
The Prognostic and Predictive Role of Clinical, Biochemical, Pathological and Molecular Characteristics of Patients With Biliary Tract Cancer: an Observational Monocentric Study. (BABEL)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
560 participants
Start Date
May 15, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
BABEL is an observational, single-center, prospective study about patients affected by biliary tract cancers (BTC) treated at the Medical Oncology Unit of the FPUAG - IRCCS.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patients with biliary tract cancer;
- Patients with radiological evident disease;
- Patients >18 anni;
- Written informed consent;
- Patients with at least one oncological visit.
Exclusion Criteria3
- Patients without available clinical data;
- Patients without histological diagnosis of BTC;
- Patients without written informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05942807
Related Trials
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
NCT062391946 locations
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
NCT0702106617 locations
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer
NCT075696791 location
Study for AZD4360 in Participants With Advanced Solid Tumours
NCT0692192818 locations
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
NCT0577515960 locations